Pharmaceutical Strategic Alliances: Sharing and Optimizing Risk

If there was an overriding theme at this year's PSA, it was the search for balance of risk in pharma-biotech collaborations. PSA also showcased Big Pharma's efforts to expand in large molecules, and its attempts to dilute risk internally, by adopting the strategic habits of biotech companies.

By Windhover Staff

If there was an overriding theme at Windhover’s Pharmaceutical Strategic Alliances conference this year, it was the search for balance—or...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Business Strategy

More from In Vivo